Case number 1:23-cv-00358
Par Pharmaceutical, Inc. et al v. Baxter Healthcare Corporation > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 9, 2024 | 116 | Amended Complaint* (1) |
| Jun 27, 2024 | 102 | NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief, and the Reply Declaration of Zlatan Coralic, Pharm.D., BCPS, FASHP in support filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(Ekiner, Kaan) (Entered: 06/27/2024) (2) |
| Jun 6, 2024 | 101 | NOTICE OF SERVICE of Baxter Healthcare Corporation's Answering Claim Construction Brief, and Declaration of Michael Freudiger, Pharm. D., APH, BCPS, BCSCP In Support of Baxter Healthcare Corporation's Answering Claim Construction Brief filed by Baxter Healthcare Corporation.(Rovner, Philip) (Entered: 06/06/2024) (2) |
| May 23, 2024 | 100 | NOTICE OF SERVICE of Plaintiffs Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC's Objections and Responses to Baxter Healthcare Corporation's Second Set of Rule 33 Interrogatories (No. 10) filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(Ekiner, Kaan) (Entered: 05/23/2024) (2) |
| May 9, 2024 | 99 | NOTICE OF SERVICE of Plaintiffs Opening Claim Construction Brief, and the Declaration of Zlatan Coralic, Pharm.D., BCPS, FASHP in support filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(Ekiner, Kaan) (Entered: 05/09/2024) (2) |
| May 7, 2024 | 97 | Joint STATUS REPORT by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Ekiner, Kaan) (Entered: 05/07/2024) (4) |
| May 7, 2024 | 98 | ORAL ORDER- re 97 Status Report. Having been advised by the parties that there are no matters requiring judicial action, IT IS HEREBY ORDERED that the status teleconference set in this matter for June 5, 2024 at 10:00 a.m. is CANCELLED. Ordered by Judge Sherry R. Fallon on 5/7/2024. (lih) (Entered: 05/07/2024) (0) |
| Apr 25, 2024 | 94 | CLAIM Construction Chart by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Ekiner, Kaan) (Entered: 04/25/2024) (0) |
| Apr 25, 2024 | 95 | MOTION for Claim Construction re 94 Claim Construction Chart, - filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. Motions referred to Sherry R. Fallon.(Ekiner, Kaan) (Entered: 04/25/2024) (2) |
| Apr 25, 2024 | 96 | MOTION for Claim Construction re 94 Claim Construction Chart, - filed by Baxter Healthcare Corporation. Motions referred to Sherry R. Fallon.(Rovner, Philip) (Entered: 04/25/2024) (1) |
| Apr 2, 2024 | 93 | NOTICE OF SERVICE of Baxter Healthcare Corporation's Second Set of Rule 33 Interrogatories (No. 10) filed by Baxter Healthcare Corporation.(Rovner, Philip) (Entered: 04/02/2024) (2) |
| Mar 27, 2024 | 92 | NOTICE OF SERVICE of Baxter Healthcare Corporation's Preliminary Invalidity Contentions Regarding U.S. Patent Nos. 9,993,520, 11,135,265, and 11,207,372 filed by Baxter Healthcare Corporation.(Rovner, Philip) (Entered: 03/27/2024) (2) |
| Mar 19, 2024 | 91 | NOTICE OF SERVICE of (1) Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC's Objections and Responses to Baxter Healthcare Corporation's Fourth Set of Requests for Production of Documents and Things (Nos. 16-84); and (2) Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC's Objections and Responses to Baxter Healthcare Corporation's First Set of Rule 33 Interrogatories (Nos. 1-9) filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(Ekiner, Kaan) (Entered: 03/19/2024) (2) |
| Mar 12, 2024 | 90 | MEMORANDUM OPINION and Order: It is hereby ORDERED that: 1. Judge Fallon's Report and Recommendation dated November 3, 2023, (D.I. 52), is ADOPTED in its entirety; 2. Defendant's Objections, (D.I. 69), are OVERRULED; 3. Defendant's Motion for Judgment on the Pleadings, (D.I. 17), is DENIED; and 4. Plaintiffs' Motion for Injunctive Relief, (D.I. 22), is DENIED. Signed by Judge Gregory B. Williams on 3/12/24. (ntl) (Entered: 03/12/2024) (9) |
| Mar 1, 2024 | 89 | NOTICE OF SERVICE of Defendant Baxter Healthcare Corporation's First Supplemental Responses and Objections to Plaintiffs Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC's First Set of Requests for Production of Documents and Things (Nos. 1-76) [Highly Confidential] filed by Baxter Healthcare Corporation.(Rovner, Philip) (Entered: 03/01/2024) (2) |
| Feb 20, 2024 | 88 | NOTICE OF SERVICE of Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC's Objections and Responses to Baxter Healthcare Corporation's Third Set of Requests for Production of Documents and Things (Nos. 12-15) filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(Ekiner, Kaan) (Entered: 02/20/2024) (2) |
| Feb 9, 2024 | 87 | NOTICE OF SERVICE of Baxter Healthcare Corporation's Fourth Set of Requests for Production of Documents and Things (Nos. 16-84); Baxter Healthcare Corporation's First Set of Rule 33 Interrogatories (Nos. 1-9) filed by Baxter Healthcare Corporation.(Rovner, Philip) (Entered: 02/09/2024) (2) |
| Jan 25, 2024 | 86 | NOTICE OF SERVICE of Plaintiffs' Infringement Contentions filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(Ekiner, Kaan) (Entered: 01/25/2024) (2) |
| Jan 18, 2024 | 85 | NOTICE OF SERVICE of Baxter Healthcare Corporation's Third Set of Requests for Production of Documents and Things (Nos. 12-15) filed by Baxter Healthcare Corporation.(Rovner, Philip) (Entered: 01/18/2024) (2) |
| Dec 28, 2023 | 84 | NOTICE of withdrawal of Jonathan A. Choa by Baxter Healthcare Corporation (Choa, Jonathan) (Entered: 12/28/2023) (1) |
| Dec 26, 2023 | 83 | REDACTED VERSION of 80 MOTION to Redact 64 Transcript,, by Baxter Healthcare Corporation. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Text of Proposed Order)(Rovner, Philip) (Entered: 12/26/2023) (0) |
| Dec 19, 2023 | 81 | ORAL ORDER re 80 MOTION to Redact 64 Transcript: IT IS ORDERED that the motion to redact the transcript of the teleconference on November 7, 2023 is GRANTED. There is good cause to redact confidential business information that could cause competitive harm if disclosed. See In re Avandia Mktg., Sales Practices & Prods. Liab. Litig., 924 F.3d 662, 672 (3d Cir. 2019). Signed by Judge Sherry R. Fallon on 12/19/2023. (Polito, Rebecca) (Entered: 12/19/2023) (0) |
| Dec 19, 2023 | 82 | Official Transcript of Status Conference held on 11/7/2023 before Judge Fallon. Court Reporter/Transcriber Deanna Warner, Email: deanna_warner@ded.uscourts.gov. (Polito, Rebecca) (Entered: 12/19/2023) (0) |
| Dec 18, 2023 | 80 | [SEALED] MOTION to Redact 64 Transcript,, - filed by Baxter Healthcare Corporation. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Text of Proposed Order)Motions referred to Sherry R. Fallon.(Rovner, Philip) (Entered: 12/18/2023) (0) |
| Dec 14, 2023 | 79 | NOTICE OF SERVICE of Defendant Baxter Healthcare Corporation's Responses and Objections to Plaintiffs Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC's First Set of Requests for Production of Documents and Things (Nos. 1-76) filed by Baxter Healthcare Corporation.(Choa, Jonathan) (Entered: 12/14/2023) (2) |
| Dec 7, 2023 | 78 | NOTICE of Intent to Request Redaction by Philip A. Rovner re 64 Transcript,, (Rovner, Philip) (Entered: 12/07/2023) (2) |
| Dec 1, 2023 | 77 | RESPONSE TO OBJECTIONS by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC re 69 Objections, . (Ekiner, Kaan) (Entered: 12/01/2023) (10) |
| Nov 29, 2023 | 76 | NOTICE OF SERVICE of Baxter's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(A)(1) filed by Baxter Healthcare Corporation.(Choa, Jonathan) (Entered: 11/29/2023) (2) |
| Nov 28, 2023 | 74 | REDACTED VERSION of 65 Letter by Baxter Healthcare Corporation. (Attachments: # 1 Exhibit A)(Rovner, Philip) Modified on 11/28/2023 (lih). (Entered: 11/28/2023) (0) |
| Nov 28, 2023 | 75 | NOTICE OF SERVICE of Baxter's Paragraph 3 Initial Disclosures filed by Baxter Healthcare Corporation.(Choa, Jonathan) (Entered: 11/28/2023) (2) |
| Nov 27, 2023 | 73 | NOTICE OF SERVICE of Plaintiffs Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC's Initial Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(Ekiner, Kaan) (Entered: 11/27/2023) (2) |
| Nov 22, 2023 | 72 | NOTICE of Lodging by Baxter Healthcare Corporation re 18 Opening Brief in Support, 47 Reply Brief, 35 Answering Brief in Opposition, 17 MOTION for Judgment on the Pleadings , 52 REPORT AND RECOMMENDATIONS re 17 MOTION for Judgment on the Pleadings filed by Baxter Healthcare Corporation, 22 MOTION for Preliminary Injunction and Temporary Restraining Order filed by Endo Par Innovation Company, LLC, Par Pha (Rovner, Philip) (Entered: 11/22/2023) (2) |
| Nov 20, 2023 | 70 | REDACTED VERSION of 60 [SEALED] Unopposed MOTION to Redact Portions re 52 REPORT AND RECOMMENDATIONS by Baxter Healthcare Corporation. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Rovner, Philip) (Entered: 11/20/2023) (0) |
| Nov 20, 2023 | 71 | NOTICE OF SERVICE of (1) Plaintiffs Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC's Objections and Responses to Baxter Healthcare Corporation's First Set of Requests for Production of Documents and Things (Nos. 1-10); and (2) Plaintiffs Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC's Objections and Responses to Baxter Healthcare Corporation's Second Set of Requests for Production of Documents and Things (No. 11) filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(Ekiner, Kaan) (Entered: 11/20/2023) (2) |
| Nov 17, 2023 | 68 | REDACTED VERSION of 52 REPORT AND RECOMMENDATIONS. (lih) (Entered: 11/17/2023) (23) |
| Nov 17, 2023 | 69 | OBJECTIONS by Baxter Healthcare Corporation to 52 REPORT AND RECOMMENDATIONS re 17 MOTION for Judgment on the Pleadings filed by Baxter Healthcare Corporation, 22 MOTION for Preliminary Injunction and Temporary Restraining Order filed by Endo Par Innovation Company, LLC, Par Pha . (Attachments: # 1 Certification to Objections)(Rovner, Philip) (Entered: 11/17/2023) (0) |
| Nov 16, 2023 | 64 | Official Transcript of Status Conference held on 11/7/23 before Judge Sherry Fallon. Court Reporter Deanna Warner, Email: deanna_warner@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/7/2023. Redacted Transcript Deadline set for 12/18/2023. Release of Transcript Restriction set for 2/14/2024. (Warner, Deanna) (Entered: 11/16/2023) (0) |
| Nov 16, 2023 | 65 | [SEALED] Letter to The Honorable Sherry R. Fallon from Philip A. Rovner regarding revised proposed redacted Report and Recommendation . (Attachments: # 1 Exhibit A)(Rovner, Philip) Modified on 11/16/2023 (lih). (Entered: 11/16/2023) (0) |
| Nov 16, 2023 | 66 | ORAL ORDER- re 65 Letter. IT IS HEREBY ORDERED that the parties shall submit a redacted version of 52 REPORT AND RECOMMENDATIONS for purposes of publishing on the public docket, by no later than close of business on 11/17/2023. Ordered by Judge Sherry R. Fallon on 11/16/2023. (lih) (Entered: 11/16/2023) (0) |
| Nov 16, 2023 | 67 | Letter to The Honorable Sherry R. Fallon from Philip A. Rovner regarding Redacted Report and Recommendations - re 65 Letter. (Attachments: # 1 Exhibit A)(Rovner, Philip) (Entered: 11/16/2023) (0) |
| Nov 14, 2023 | 61 | ORAL ORDER re 60 Motion to Redact: IT IS ORDERED that the unopposed motion to redact portions of the Courts November 3 Report and Recommendations is GRANTED-IN-PART. The motion is DENIED with respect to the word buffer which, standing alone, does not reveal commercially sensitive information to any greater degree than what has already been publicly disclosed at D.I. 38-1, and eliminating the word from the Report and Recommendation could interfere with its interpretation. The motion is GRANTED in all other respects. On or before November 16, 2023, the parties shall submit a revised proposed redacted Report and Recommendation consistent with this Oral Order. Ordered by Judge Sherry R. Fallon on 11/14/2023. (lih) (Entered: 11/14/2023) (0) |
| Nov 14, 2023 | 62 | REDACTED VERSION of 55 Letter by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Ekiner, Kaan) (Entered: 11/14/2023) (3) |
| Nov 14, 2023 | 63 | NOTICE OF SERVICE of Plaintiffs Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC's First Set of Requests for Production of Documents and Things (Nos. 1-76) to Defendant Baxter Healthcare Corporation filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(Ekiner, Kaan) (Entered: 11/14/2023) (2) |
| Nov 13, 2023 | 60 | [SEALED] Unopposed MOTION to Redact Portions re 52 REPORT AND RECOMMENDATIONS - filed by Baxter Healthcare Corporation. (Attachments: # 1 Exhibit A, # 2 Exhibit B)Motions referred to Sherry R. Fallon.(Rovner, Philip) Modified on 11/14/2023 (lih). (Entered: 11/13/2023) (0) |
| Nov 10, 2023 | 59 | NOTICE OF SERVICE of (1) Plaintiffs' Disclosure of Accused Products and Asserted Patent Claims; and (2) Plaintiffs' Initial Disclosures Pursuant to Rule 26(a)(1) filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(Ekiner, Kaan) (Entered: 11/10/2023) (2) |
| Nov 8, 2023 | 56 | REDACTED VERSION of 18 Opening Brief in Support by Baxter Healthcare Corporation. (Rovner, Philip) Modified on 11/9/2023 (lih). (Entered: 11/08/2023) (26) |
| Nov 8, 2023 | 57 | REDACTED VERSION of 47 Reply Brief by Baxter Healthcare Corporation. (Rovner, Philip) Modified on 11/9/2023 (lih). (Entered: 11/08/2023) (14) |
| Nov 8, 2023 | 58 | REDACTED VERSION of 35 Answering Brief in Opposition, by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Ekiner, Kaan) (Entered: 11/08/2023) (25) |
| Nov 7, 2023 | 55 | [SEALED] Joint Letter to The Honorable Sherry R. Fallon from Kaan Ekiner - re 54 Oral Order. (Ekiner, Kaan) Modified on 11/7/2023 (lih). (Entered: 11/07/2023) (0) |
| Nov 6, 2023 | 53 | ORAL ORDER- GRANTING 51 Letter Request to seal exhibits 9-4 of D.I. 38 ; exhibits B-1 and B-2 of D.I. 44 ; exhibits 44 and 72 of D.I. 45 ; and the filing of redacted exhibit 4 to D.I. 44 . Baxter has demonstrated that the documents contain commercially sensitive information that would "work a clearly defined and serious injury to the party seeking closure." See In re Avandia Mktg., Sales Practices & Prods. Liab. Litig., 924 F.3d 662, 672 (3d Cir. 2019) (quoting Miller v. Ind. Hosp., 16 F.3d 549, 551 (3d Cir. 1994) (internal quotation marks omitted)). Ordered by Judge Sherry R. Fallon on 11/6/2023. (lih) (Entered: 11/06/2023) (0) |
| Nov 6, 2023 | 54 | ORAL ORDER re 50 Oral Order Setting Teleconference: IT IS ORDERED that, on or before November 7, 2023 at 12:00 p.m., the parties shall submit a joint status report of no more than four pages (two pages per side) in advance of the teleconference on the same date. The status report shall indicate whether the parties have reached any further agreements since the issuance of the Court's November 3 Report and Recommendation, and/or whether the purpose of the teleconference is now moot and may be removed from the Court's calendar. Ordered by Judge Sherry R. Fallon on 11/6/2023. (lih) (Entered: 11/06/2023) (0) |
| Nov 3, 2023 | 52 | [SEALED] REPORT AND RECOMMENDATIONS- re 17 MOTION for Judgment on the Pleadings, 22 MOTION for Preliminary Injunction and Temporary Restraining Order. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 11/17/2023. Signed by Judge Sherry R. Fallon on 11/3/2023.This order has been emailed to local counsel. (lih) (Entered: 11/03/2023) (0) |
| Oct 31, 2023 | 51 | Letter to The Honorable Sherry R. Fallon from Philip A. Rovner regarding redactions - re 46 Oral Order. (Attachments: # 1 Exhibit 4)(Rovner, Philip) Modified on 11/1/2023 (lih). (Entered: 10/31/2023) (0) |
| Oct 27, 2023 | 49 | SCHEDULING ORDER: Joinder of Parties due by 9/5/2024. Amended Pleadings due by 9/5/2024. Discovery due by 11/14/2024. Opening Expert Reports due by 12/19/2024. Rebuttal Expert Reports due by 2/6/2025. Reply Expert Reports due by 3/6/2025. Expert Discovery due by 5/1/2025. A Status Conference is set for 6/5/2024 at 10:00 AM before Judge Sherry R. Fallon. Status Report due by 5/7/2024. A Markman Hearing is set for 9/4/2024 at 11:00 AM in Courtroom 6C before Judge Sherry R. Fallon. Proposed Pretrial Order due by 9/23/2025. A Pretrial Conference is set for 9/30/2025 at 03:00 PM in Courtroom 6B before Judge Gregory B. Williams. A 5-day Bench Trial is set to begin on 10/6/2025 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams. (PLEASE REFER TO SCHEDULING ORDER FOR FURTHER DETAILS.) Signed by Judge Sherry R. Fallon on 10/27/2023. (lih) (Entered: 10/27/2023) (16) |
| Oct 27, 2023 | 50 | ORAL ORDER re 26 : In accordance with the parties' joint request made during the oral argument held on October 27, 2023, IT IS ORDERED that a status teleconference will be held on November 7, 2023 at 4:00 p.m. Ordered by Judge Sherry R. Fallon on 10/27/2023. (lih) (Entered: 10/27/2023) (0) |
| Oct 26, 2023 | 48 | Joint Letter to The Honorable Sherry R. Fallon from Kaan Ekiner regarding oral argument on 10/27/2023 . (Ekiner, Kaan) Modified on 10/26/2023 (lih). (Entered: 10/26/2023) (1) |
| Oct 25, 2023 | 47 | [SEALED] REPLY BRIEF re 17 MOTION for Judgment on the Pleadings filed by Baxter Healthcare Corporation. (Rovner, Philip) (Entered: 10/25/2023) (0) |
| Oct 24, 2023 | 46 | ORAL ORDER re D.I. 38 redacting Exhibits 9-14 in their entirety; D.I. 44 redacting Exhibits B-1, B-2 and Exhibit 4 in their entirety; and D.I. 45 redacting Exhibits 46 and 72 in their entirety: On or before close of business on October 31, 2023, the party or parties requesting the redactions shall submit a letter of no more than three (3) pages offering a factually detailed explanation as to why disclosure of the redacted material would "work a clearly defined and serious injury to the party seeking closure." See In re Avandia Mktg., Sales Practices & Prods. Liab. Litig., 924 F.3d 662, 672 (3d Cir. 2019) (quoting Miller v. Ind. Hosp., 16 F.3d 549, 551 (3d Cir. 1994) (internal quotation marks omitted)). Absent a compelling reason, supported by a statement under oath by a party, redactions in their entirety are impermissible; redactions must be done so as to redact the least possible amount of the materials submitted. Redacting in its entirety a document, or parts of it, that contains publicly available materials is prima facie evidence of bad faith. If the Court determines that the decision to seal Exhibits 9-14 (D.I. 38 ); Exhibits B-1, B-2 and Exhibit 4 (D.I. 44 ) and Exhibits 46 and 72 (D.I. 45 ) in their entirety lacks a meritorious basis after review of the letter submission, the documents will be unsealed either in whole or in part. Ordered by Judge Sherry R. Fallon on 10/24/2023. (lih) (Entered: 10/24/2023) (0) |
| Oct 23, 2023 | 36 | REDACTED VERSION of 22 MOTION for Preliminary Injunction and Temporary Restraining Order by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Attachments: # 1 LR 7.1.1 Statement, # 2 Text of Proposed Order)(Ekiner, Kaan) (Entered: 10/23/2023) (0) |
| Oct 23, 2023 | 37 | REDACTED VERSION of 23 Opening Brief in Support, by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Ekiner, Kaan) (Entered: 10/23/2023) (27) |
| Oct 23, 2023 | 38 | REDACTED VERSION of 24 Declaration,,, by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15 - Kirsch Declaration, # 16 Exhibit 16 - Coralic Declaration, # 17 Exhibit 17 - Sims Declaration, # 18 Exhibit 18 - Stanton Declaration, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24)(Ekiner, Kaan) (Entered: 10/23/2023) (0) |
| Oct 23, 2023 | 39 | REDACTED VERSION of 25 Letter by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Ekiner, Kaan) (Entered: 10/23/2023) (1) |
| Oct 23, 2023 | 40 | REDACTED VERSION of 33 Reply Brief by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Ekiner, Kaan) (Entered: 10/23/2023) (10) |
| Oct 23, 2023 | 41 | REDACTED VERSION of 34 Declaration,, by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Attachments: # 1 Exhibit 25 - Kirsch Supplemental Declaration, # 2 Exhibit 26 - Coralic Supplemental Declaration, # 3 Exhibit 27 - Sims Supplemental Declaration, # 4 Exhibit 28 - Stanton Supplemental Declaration, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34)(Ekiner, Kaan) (Entered: 10/23/2023) (0) |
| Oct 23, 2023 | 42 | Joint PROPOSED Scheduling oRDER by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Attachments: # 1 Letter)(Ekiner, Kaan) Modified on 10/24/2023 (lih). (Entered: 10/23/2023) (0) |
| Oct 23, 2023 | 43 | REDACTED VERSION of 29 Answering Brief in Opposition by Baxter Healthcare Corporation. (Rovner, Philip) Modified on 10/24/2023 (lih). (Entered: 10/23/2023) (29) |
| Oct 23, 2023 | 44 | REDACTED VERSION of 30 Declaration by Baxter Healthcare Corporation. (Attachments: # 1 Exhibit 1-32)(Rovner, Philip) Modified on 10/24/2023 (lih). (Entered: 10/23/2023) (0) |
| Oct 23, 2023 | 45 | REDACTED VERSION of 31 Declaration by Baxter Healthcare Corporation. (Attachments: # 1 Exhibit 33-72)(Rovner, Philip) Modified on 10/24/2023 (lih). (Entered: 10/23/2023) (0) |
| Oct 18, 2023 | 35 | [SEALED] ANSWERING BRIEF in Opposition re 17 MOTION for Judgment on the Pleadings filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.Reply Brief due date per Local Rules is 10/25/2023. (Ekiner, Kaan) (Entered: 10/18/2023) (0) |
| Oct 16, 2023 | 33 | [SEALED] REPLY BRIEF re 22 MOTION for Preliminary Injunction and Temporary Restraining Order filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Ekiner, Kaan) (Entered: 10/16/2023) (0) |
| Oct 16, 2023 | 34 | [SEALED] DECLARATION of Kaan Ekiner re 33 Reply Brief by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Attachments: # 1 Exhibit 25 - Kirsch Supplemental Declaration, # 2 Exhibit 26 - Coralic Supplemental Declaration, # 3 Exhibit 27 - Sims Supplemental Declaration, # 4 Exhibit 28 - Stanton Supplemental Declaration, # 5 Exhibit 29, # 6 Exhibit 30, # 7 Exhibit 31, # 8 Exhibit 32, # 9 Exhibit 33, # 10 Exhibit 34)(Ekiner, Kaan) Modified on 10/17/2023 (lih). (Entered: 10/16/2023) (0) |
| Oct 13, 2023 | 32 | ORAL ORDER SETTING RULE 16(b) CONFERENCE: IT IS HEREBY ORDERED that: (1) A scheduling conference pursuant to Fed. R. Civ. P. 16(b) will be held on October 27, 2023 at 10:00 A.M. in Courtroom 6C. (2) The parties are required to prepare for the teleconference by conferring on all matters under Rule 16 and D. Del. LR 16 and shall submit a proposed Scheduling Order to the Court no later than October 23, 2023. The Court's form of scheduling order is posted at https://www.ded.uscourts.gov/judge/magistrate-judge-sherry-r-fallon. Portions of the proposed scheduling order falling outside the scope of the referral to the Magistrate Judge (such as summary judgment motions, Daubert motions, pre-trial motions in limine, the pre-trial conference, and trial) shall conform with Judge Williams' form of scheduling order found at https://www.ded.uscourts.gov/judge/judge-gregory-b-williams. If the parties have any suggestions or modifications to the standard Scheduling Order, they may be included in the proposed order for consideration by the Court. (3) If any disputed issue exists regarding the proposed Scheduling Order, it shall be noted therein, along with the parties' proposed language on the issue for consideration by the Court. Ordered by Judge Sherry R. Fallon on 10/13/2023. (lih) (Entered: 10/13/2023) (0) |
| Oct 12, 2023 | 29 | [SEALED] ANSWERING BRIEF in Opposition re 22 MOTION for Preliminary Injunction and Temporary Restraining Order filed by Baxter Healthcare Corporation.Reply Brief due date per Local Rules is 10/19/2023. (Rovner, Philip) (Entered: 10/12/2023) (0) |
| Oct 12, 2023 | 30 | [SEALED] DECLARATION of Katie A. Boda Volume 1 of 2 re 29 Answering Brief in Opposition by Baxter Healthcare Corporation. (Attachments: # 1 Exhibit 1-32)(Rovner, Philip) Modified on 10/13/2023 (lih). (Entered: 10/12/2023) (0) |
| Oct 12, 2023 | 31 | [SEALED] DECLARATION of Katie A. Boda Volume 2 of 2 re 29 Answering Brief in Opposition by Baxter Healthcare Corporation. (Attachments: # 1 Exhibit 33-72)(Rovner, Philip) Modified on 10/13/2023 (lih). (Entered: 10/12/2023) (0) |
| Oct 11, 2023 | 28 | STIPULATION TO EXTEND TIME for the parties to file redacted versions of any papers filed under seal in connection with Plaintiffs' Motion for a Preliminary Injunction and Temporary Restraining Order to October 23, 2023 - filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Ekiner, Kaan) (Entered: 10/11/2023) (2) |
| Oct 5, 2023 | 26 | ORAL ORDER: Having received Plaintiffs' motion for temporary restraining order and preliminary injunction and related materials (D.I. 22, D.I. 23, D.I. 24, D.I. 25), IT IS ORDERED that: (1) Defendant shall file its opposition to the TRO and preliminary injunction on or before October 12, 2023; (2) Plaintiffs shall file a reply brief, not to exceed five pages, no later than October 16, 2023; and (3) the Court will hear oral argument on the motion on October 27, 2023 at 10:00 a.m. in Courtroom 6C. IT IS FURTHER ORDERED that, on or before October 26, 2023, the parties shall file a joint letter setting forth how much time is requested for the hearing, the identification of counsel who will argue for each side, and whether any newer attorneys who have been practicing for less than seven years will be arguing. Any slide presentations the parties plan to use during the argument should be emailed (in PDF format) to Rebecca_Polito@ded.uscourts.gov by no later than October 26, 2023. Ordered by Judge Sherry R. Fallon on 10/5/2023. (lih) (Entered: 10/05/2023) (0) |
| Oct 5, 2023 | 27 | [SEALED] Letter to The Honorable Sherry R. Fallon from Philip A. Rovner regarding Plaintiffs' October 4, 2023 letter - re 25 Letter. (Rovner, Philip) (Entered: 10/05/2023) (0) |
| Oct 4, 2023 | 21 | ORAL ORDER REFERRING CASE TO Magistrate Judge Sherry R. Fallon: IT IS HEREBY ORDERED that the above-captioned case is referred to Magistrate Judge Sherry R. Fallon to hear and resolve all pre-trial matters up to and including expert discovery matters (but not including summary judgment motions, Daubert motions, pre-trial motions in limine, or the pre-trial conference), subject to 28 U.S.C. §636(b) and any further Order of the Court. ORDERED by Judge Gregory B. Williams on 10/4/23. (ntl) (Entered: 10/04/2023) (0) |
| Oct 4, 2023 | 22 | [SEALED] MOTION for Preliminary Injunction and Temporary Restraining Order - filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Attachments: # 1 LR 7.1.1 Statement, # 2 Text of Proposed Order)Motions referred to Sherry R. Fallon.(Ekiner, Kaan) Modified on 10/4/2023 (lih). (Entered: 10/04/2023) (0) |
| Oct 4, 2023 | 23 | [SEALED] OPENING BRIEF in Support re 22 MOTION for Preliminary Injunction and Temporary Restraining Order filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.Answering Brief/Response due date per Local Rules is 10/18/2023. (Ekiner, Kaan) (Entered: 10/04/2023) (0) |
| Oct 4, 2023 | 24 | [SEALED] DECLARATION of Kaan Ekiner re 22 MOTION for Preliminary Injunction and Temporary Restraining Order by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15 - Kirsch Declaration, # 16 Exhibit 16 - Coralic Declaration, # 17 Exhibit 17 - Sims Declaration, # 18 Exhibit 18 - Stanton Declaration, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24)(Ekiner, Kaan) Modified on 10/5/2023 (lih). (Entered: 10/04/2023) (0) |
| Oct 4, 2023 | 25 | [SEALED] Letter to The Honorable Gregory B. Williams from Kaan Ekiner - re 22 MOTION for Preliminary Injunction and Temporary Restraining Order. (Ekiner, Kaan) (Entered: 10/04/2023) (0) |
| Sep 29, 2023 | 20 | STIPULATION TO EXTEND TIME for Plaintiffs to respond to Defendant's Motion for Judgment on the Pleadings to October 18, 2023 - filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Ekiner, Kaan) (Entered: 09/29/2023) (2) |
| Sep 25, 2023 | 19 | NOTICE OF SERVICE of Baxter Healthcare Corporation's Second Set of Requests for Production of Documents and Things (No.11) filed by Baxter Healthcare Corporation.(Choa, Jonathan) (Entered: 09/25/2023) (2) |
| Sep 20, 2023 | 17 | MOTION for Judgment on the Pleadings - filed by Baxter Healthcare Corporation. (Attachments: # 1 Text of Proposed Order)(Rovner, Philip) (Entered: 09/20/2023) (0) |
| Sep 20, 2023 | 18 | [SEALED] OPENING BRIEF in Support re 17 MOTION for Judgment on the Pleadings filed by Baxter Healthcare Corporation.Answering Brief/Response due date per Local Rules is 10/4/2023. (Rovner, Philip) (Entered: 09/20/2023) (0) |
| Sep 19, 2023 | 16 | NOTICE OF SERVICE of Baxter Healthcare Corporation's First Set of Requests for Production of Documents and Things (Nos. 1-10) filed by Baxter Healthcare Corporation.(Choa, Jonathan) (Entered: 09/19/2023) (2) |
| Sep 13, 2023 | 15 | Joint PROPOSED ORDER - Proposed Protective Order by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Ekiner, Kaan) (Entered: 09/13/2023) (27) |
| Sep 5, 2023 | 13 | [SEALED] ANSWER to 8 Answer to Complaint,, Counterclaim, by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(Ekiner, Kaan) (Entered: 09/05/2023) (0) |
| Sep 5, 2023 | 14 | REDACTED VERSION of 13 Answer to Counterclaim by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Ekiner, Kaan) (Entered: 09/05/2023) (30) |
| Aug 25, 2023 | 12 | MOTION for Pro Hac Vice Appearance of Attorney Kerry B. McTigue, W. Blake Coblentz, Aaron S. Lukas, Keri L. Schaubert, and Madison H. McNulty - filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Ekiner, Kaan) (Entered: 08/25/2023) (7) |
| Aug 17, 2023 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Paul J. Molino, Kevin E. Warner, Katie A. Boda and Greg L. Goldblatt - filed by Baxter Healthcare Corporation. (Choa, Jonathan) (Entered: 08/17/2023) (5) |
| Aug 15, 2023 | 10 | REDACTED VERSION of 8 Answer to Complaint,, Counterclaim, by Baxter Healthcare Corporation. (Attachments: # 1 Exhibit A-L)(Rovner, Philip) (Entered: 08/15/2023) (0) |
| Aug 14, 2023 | 8 | [SEALED] ANSWER to 1 Complaint, , COUNTERCLAIM against Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC by Baxter Healthcare Corporation. (Attachments: # 1 Exhibit A-L)(Rovner, Philip) (Entered: 08/14/2023) (0) |
| Aug 14, 2023 | 9 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Baxter International, Inc. for Baxter Healthcare Corporation filed by Baxter Healthcare Corporation. (Rovner, Philip) (Entered: 08/14/2023) (1) |
| Jun 16, 2023 | 7 | WAIVER OF SERVICE returned executed by Par Pharmaceutical, Inc., Par Sterile Products, LLC, Endo Par Innovation Company, LLC: For Baxter Healthcare Corporation waiver sent on 6/15/2023, answer due 8/14/2023. (Ekiner, Kaan) (Entered: 06/16/2023) (1) |
| Apr 5, 2023 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 04/05/2023) (0) |
| Mar 29, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Baxter Healthcare Corporation (Filing fee $ 402, receipt number ADEDC-4100576.) - filed by Par Pharmaceutical, Inc., Par Sterile Products, LLC, Endo Par Innovation Company, LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(jfm) (Entered: 03/30/2023) (Main Document) (15) |
| Mar 29, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 03/30/2023) (3) |
| Mar 29, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: January 30, 2035. Thirty Month Stay Deadline: N/A. (jfm) (Entered: 03/30/2023) (1) |
| Mar 29, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,993,520; US 11,135,265; US 11,207,372. (jfm) (Entered: 03/30/2023) (1) |
| Mar 29, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Par Pharmaceutical, Inc. for Endo Par Innovation Company, LLC and Par Sterile Products, LLC; Corporate Parent Endo International PLC for Par Pharmaceutical, Inc. filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (jfm) (Entered: 03/30/2023) (2) |
| Mar 29, 2023 | 6 | Summons Issued as to Baxter Healthcare Corporation on 3/29/2023. (jfm) (Entered: 03/30/2023) (2) |
| Mar 29, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Baxter Healthcare Corporation (Filing fee $ 402, receipt number ADEDC-4100576.) - filed by Par Pharmaceutical, Inc., Par Sterile Products, LLC, Endo Par Innovation Company, LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(jfm) (Entered: 03/30/2023) (Exhibit A) (30) |
| Mar 29, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Baxter Healthcare Corporation (Filing fee $ 402, receipt number ADEDC-4100576.) - filed by Par Pharmaceutical, Inc., Par Sterile Products, LLC, Endo Par Innovation Company, LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(jfm) (Entered: 03/30/2023) (Exhibit B) (30) |
| Mar 29, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Baxter Healthcare Corporation (Filing fee $ 402, receipt number ADEDC-4100576.) - filed by Par Pharmaceutical, Inc., Par Sterile Products, LLC, Endo Par Innovation Company, LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(jfm) (Entered: 03/30/2023) (Exhibit C) (30) |
| Mar 29, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Baxter Healthcare Corporation (Filing fee $ 402, receipt number ADEDC-4100576.) - filed by Par Pharmaceutical, Inc., Par Sterile Products, LLC, Endo Par Innovation Company, LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(jfm) (Entered: 03/30/2023) (Civil Cover Sheet) (1) |
